<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7600130</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5844</journal-id>
<journal-id journal-id-type="nlm-ta">Neurosci Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci. Lett.</journal-id>
<journal-title-group>
<journal-title>Neuroscience letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0304-3940</issn>
<issn pub-type="epub">1872-7972</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28827127</article-id>
<article-id pub-id-type="pmc">5816698</article-id>
<article-id pub-id-type="doi">10.1016/j.neulet.2017.08.035</article-id>
<article-id pub-id-type="manuscript">NIHMS901772</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Evidence for a role of plasma membrane calcium pumps in neurodegenerative disease: Recent developments</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Strehler</surname>
<given-names>Emanuel E.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thayer</surname>
<given-names>Stanley A.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA</aff>
<aff id="A2">
<label>b</label>Department of Biomedicine, University of Basel, Basel, Switzerland</aff>
<aff id="A3">
<label>c</label>Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, USA</aff>
<author-notes>
<corresp id="FN1"><label>1</label>Address for correspondence: Emanuel E. Strehler, Ph.D., Mayo Clinic College of Medicine and Science, Emeritus Staff Center, Plummer N10, 200 First Street SW, Rochester, MN 55905, USA, <email>strehler.emanuel@mayo.edu</email></corresp>
<corresp id="FN2"><label>2</label>Address for correspondence: Stanley A. Thayer, Ph.D., Department of Pharmacology, University of Minnesota Medical School, 6-120 Jackson Hall, 321 Church Street, Minneapolis, MN55455, USA, <email>sathayer@umn.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>10</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>663</volume>
<fpage>39</fpage>
<lpage>47</lpage>
<!--elocation-id from pubmed: 10.1016/j.neulet.2017.08.035-->
<abstract id="Abs1">
<p id="P2">Plasma membrane Ca<sup>2+</sup> ATPases (PMCAs) are a major system for calcium extrusion from all cells. Different PMCA isoforms and splice variants are involved in the precise temporal and spatial handling of Ca<sup>2+</sup> signals and the re-establishment of resting Ca<sup>2+</sup> levels in the nervous system. Lack or inappropriate expression of specific PMCAs leads to characteristic neuronal phenotypes, which may be reciprocally exacerbated by genetic predisposition through alleles in other genes that modify PMCA interactions, regulation, and function. PMCA dysfunction is often poorly compensated in neurons and may lead to changes in synaptic transmission, altered excitability and, with long-term calcium overload, eventual cell death. Decrease and functional decline of PMCAs are hallmarks of neurodegeneration during aging, and mutations in specific PMCAs are responsible for neuronal dysfunction and accelerated neurodegeneration in many sensory and cognitive diseases.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical Abstract</title>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms901772u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>Calcium homeostasis</kwd>
<kwd>cerebellar ataxia</kwd>
<kwd>excitotoxicity</kwd>
<kwd>neurodegenerative disease</kwd>
<kwd>plasma membrane calcium ATPase</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>